AstraZeneca (Canada)

499 papers and 19.9k indexed citations i.

About

In recent decades, authors affiliated with AstraZeneca (Canada) have published 499 papers, which have received a total of 19.9k indexed citations. Scholars at this organization have produced 139 papers in Pulmonary and Respiratory Medicine, 104 papers in Physiology and 97 papers in Oncology on the topics of Asthma and respiratory diseases (63 papers), Lung Cancer Treatments and Mutations (51 papers) and Neuropeptides and Animal Physiology (41 papers). Their work is cited by papers focused on Molecular Biology (5.0k citations), Physiology (4.3k citations) and Pulmonary and Respiratory Medicine (4.0k citations). Authors at AstraZeneca (Canada) collaborate with scholars in Canada, United States and United Kingdom and have published in prestigious journals including Cell, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of AstraZeneca (Canada)'s most productive authors include Dajan O’Donnell, Alain Gendron, Émmanuel Stip, Stéphane Potvin, Édouard Kouassi, Cyrla Hoffert, Amir A. Sepehry, Françoise Mennicken, Andy Dray and Sultan Ahmad.

In The Last Decade

Fields of papers published by authors at AstraZeneca (Canada)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with AstraZeneca (Canada) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with AstraZeneca (Canada) at the time of their publication.

Countries citing scholars working at AstraZeneca (Canada)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at AstraZeneca (Canada). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AstraZeneca (Canada) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AstraZeneca (Canada) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025